Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2007, Vol. 110, No. 8, pp. 3005-3014.
Prepublished online as a Blood First Edition Paper on September 20, 2007; DOI 10.1182/blood-2007-03-079368.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Figure
Right arrow All Versions of this Article:
blood-2007-03-079368v1
blood-2007-03-079368v2
110/8/3005    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nilsson, L.
Right arrow Articles by Jacobsen, S. E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nilsson, L.
Right arrow Articles by Jacobsen, S. E. W.
Related Collections
Right arrow Gene Expression
Right arrow Genomics
Right arrow Stem Cells in Hematology
Right arrow Hematopoiesis and Stem Cells
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

The molecular signature of MDS stem cells supports a stem-cell origin of 5q– myelodysplastic syndromes

Lars Nilsson1, Patrik Edén2, Eleonor Olsson3, Robert Månsson1, Ingbritt Åstrand-Grundström1, Bodil Strömbeck4, Kim Theilgaard-Mönch5, Kristina Anderson1, Robert Hast6, Eva Hellström-Lindberg7, Jan Samuelsson8, Gösta Bergh9, Claus Nerlov1,10, Bertil Johansson4, Mikael Sigvardsson1, Åke Borg3, and Sten Eirik W. Jacobsen1

1 Hematopoietic Stem Cell Laboratory, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden; 2 Complex Systems Division, Department of Theoretical Physics, Lund University, Lund, Sweden; 3 DNA Microarray Resource Center, Department of Oncology, Lund University, Lund, Sweden; 4 Department of Clinical Genetics, Lund University, Lund, Sweden; 5 Granulocyte Research Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 6 Hematology Center, Karolinska University Hospital, Stockholm, Sweden; 7 Department of Medicine, Division of Hematology, Karolinska University Hospital (Huddinge), Stockholm, Sweden; 8 Department of Medicine, South Hospital, Karolinska Institute, Stockholm, Sweden; 9 Department of Medicine, Helsingborg Hospital, Sweden; and 10 European Molecular Biology Laboratory (EMBL), Mouse Biology Unit, Monterotondo, Italy

Global gene expression profiling of highly purified 5q-deleted CD34+CD38Thy1+ cells in 5q– myelodysplastic syndromes (MDSs) supported that they might originate from and outcompete normal CD34+CD38Thy1+ hematopoietic stem cells. Few but distinct differences in gene expression distinguished MDS and normal stem cells. Expression of BMI1, encoding a critical regulator of self-renewal, was up-regulated in 5q– stem cells. Whereas multiple previous MDS genetic screens failed to identify altered expression of the gene encoding the myeloid transcription factor CEBPA, stage-specific and extensive down-regulation of CEBPA was specifically observed in MDS progenitors. These studies establish the importance of molecular characterization of distinct stages of cancer stem and progenitor cells to enhance the resolution of stage-specific dysregulated gene expression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020